Dr Rose "played a key role in obtaining FDA approval for [TPOXX] in 2019, and he was responsible for securing contracts with BARDA under which the US Government has procured 1.7 million courses of TPOXX for more that US 1 billion into the Strategic National Stockpile (SNS).
FDA experience.
CHF focus.
& may also have something to do with emerging diseases/stockpiling experience (COVID-ARDS ??? - we can hope)?
Seems like he gets things done. Can not be a bad thing for MSB at this time.
Ann: Mesoblast Appoints Dr Eric Rose as Chief Medical Officer, page-38
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |